Literature DB >> 1823846

Session on the role of [131I]metaiodobenzylguanidine in the treatment of malignant phaeochromocytoma. Chairmen's report.

D M Ackery1, L Troncone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1823846

Source DB:  PubMed          Journal:  J Nucl Biol Med        ISSN： 0368-3249


× No keyword cloud information.
  3 in total

1.  Clinical significance of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma.

Authors:  Azusa Nakazawa; Tetsuya Higuchi; Noboru Oriuchi; Yukiko Arisaka; Keigo Endo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

2.  Giant phaeochromocytoma: case report.

Authors:  L Basso; L Lepre; M Melillo; F Fora; P L Mingazzini; A Tocchi
Journal:  Ir J Med Sci       Date:  1996 Jan-Mar       Impact factor: 1.568

3.  131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma.

Authors:  Gonca Kara Gedik; Cornelis A Hoefnagel; Evert Bais; Renato A Valdés Olmos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-11       Impact factor: 9.236
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.